Evaxion Biotech A/S
Created in 2008
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
9,270Activities
Technologies
Entity types
Location
Dr Neergaards Vej 5f, 2970 Hørsholm, Denmark
Hørsholm
Denmark
Employees
Scale: 11-50
Estimated: 60
Engaged corporates
2
0 2Added in Motherbase
1 year, 3 months ago
deeptech Value proposition
AI-ImmunologyTM Powered Vaccines
Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM platform and vaccine pipeline, please visit our website.
Immunoinformatics, Bioinformatics, Infectious Diseases, Immuno-Oncology, Vaccines, Immunotherapy, Artificial Intelligence, Antigen Discovery, Neo Epitope Discovery, AI-Immunology, AI, and Biotech
AI-Immunology™ Powered Vaccines | Evaxion Biotech
With our AI-Immunology™ platform, Evaxion harness the power of the human immune system to create novel immunotherapies for the patients of today and tomorrow.
https://www.evaxion-biotech.com/
